RecruitingNCT06458231

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital


Sponsor

Port Said University

Enrollment

600 participants

Start Date

Jun 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI. * Determine antibiotic biogram of each organism isolated * Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.


Eligibility

Min Age: 1 Day

Inclusion Criteria2

  • Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture.
  • Both sex, and all age-groups.

Exclusion Criteria2

  • Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours.
  • Samples proved contaminated by microbial flora will be rejected.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBlood Catheters

Central line as a predisposing factor for Blood stream infection


Locations(2)

Prof. Refat Sadeq

Port Said, Egypt

Faculty of Medicine Portsaid Uni

Port Said, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06458231